Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19.
Mohr-Holland E, Hacking D, Daniels J, Scott V, Mudaly V, Furin J, Pfaff C, Reuter A. Mohr-Holland E, et al. Int J Tuberc Lung Dis. 2021 Sep 1;25(9):772-775. doi: 10.5588/ijtld.21.0340. Int J Tuberc Lung Dis. 2021. PMID: 34802503 Free PMC article. No abstract available.
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients.
Mohr-Holland E, Daniels J, Douglas-Jones B, Mema N, Scott V, Trivino-Duran L, Pfaff C, Furin J, Isaakidis P. Mohr-Holland E, et al. Int J Tuberc Lung Dis. 2021 May 1;25(5):409-412. doi: 10.5588/ijtld.21.0010. Int J Tuberc Lung Dis. 2021. PMID: 33977912 Free PMC article. No abstract available.
A home-based care programme for rifampicin-resistant TB.
Douglas-Jones B, Mohr-Holland E, Mema N, Mathee S, Mathews G, Hurribance S, Scott V, Reuter A, Furin J, Pfaff C. Douglas-Jones B, et al. Int J Tuberc Lung Dis. 2021 Jul 1;25(7):587-589. doi: 10.5588/ijtld.21.0051. Int J Tuberc Lung Dis. 2021. PMID: 34183106 No abstract available.
Early mortality during rifampicin-resistant TB treatment.
Mohr-Holland E, Daniels J, Reuter A, Rodriguez CA, Mitnick C, Kock Y, Cox V, Furin J, Cox H. Mohr-Holland E, et al. Int J Tuberc Lung Dis. 2022 Feb 1;26(2):150-157. doi: 10.5588/ijtld.21.0494. Int J Tuberc Lung Dis. 2022. PMID: 35086627 Free PMC article.
How COVID-19 could benefit tuberculosis and HIV services in South Africa.
Keene C, Mohr-Holland E, Cassidy T, Scott V, Nelson A, Furin J, Triviño-Duran L. Keene C, et al. Lancet Respir Med. 2020 Sep;8(9):844-846. doi: 10.1016/S2213-2600(20)30311-8. Epub 2020 Aug 3. Lancet Respir Med. 2020. PMID: 32758439 Free PMC article. No abstract available.
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.
Cox H, Salaam-Dreyer Z, Goig GA, Nicol MP, Menardo F, Dippenaar A, Mohr-Holland E, Daniels J, Cudahy PGT, Borrell S, Reinhard M, Doetsch A, Beisel C, Reuter A, Furin J, Gagneux S, Warren RM. Cox H, et al. Among authors: mohr holland e. Lancet Microbe. 2021 Nov;2(11):e584-e593. doi: 10.1016/S2666-5247(21)00144-0. Lancet Microbe. 2021. PMID: 34766068 Free PMC article.
19 results